Prime Medicine, Inc Common Stock
Price & Volume
Stats
See more52W Range | $2.67-$6.94 |
Market Cap | $580.4M |
Shares Short | 35M |
Financials
See moreRevenue (12 Mos) | $4M |
Revenue Growth (YoY) | 3.5% |
Gross Profit (12 Mos) | -$142.1M |
Diluted EPS | -$1.04 |
News
See moreYahoo Finance • 18 days ago
Scribe’s Genetic Editing Aims to Prevent Heart Attacks
Yahoo Finance • 18 days ago
Cathie Wood's Ark Invest boosts stakes in Tesla, SpaceX, Meta, trimming Figma, Shopify
Yahoo Finance • 30 days ago
Bank of America Securities Maintains Buy Rating for Beam Therapeutics (BEAM)
Yahoo Finance • last month
Prime Medicine (PRME) Reaches Positive Resolution to Arbitration with Beam Therapeutics
About
CEO | Dr. Allan Reine M.D. |
Address | 60 First Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 146 |